4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cingulate Inc. (CING) operates in the Biotechnology industry and is headquartered in Kansas City, United States with about 14 employees. Its market capitalization is roughly $63 million. In the fiscal year ended 2025-12-31, CING reported $0M in revenue and ($22M) in net income.
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($20M) | ($16M) | ($23M) | ($18M) |
| Net Income | ($22M) | ($17M) | ($24M) | ($18M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($8M) | ($6M) | ($6M) | ($5M) | ($4M) |
| Net Income | ($9M) | ($6M) | ($7M) | ($5M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $15M | $15M | $4M | $11M | — |
| Total Liabilities | $13M | $7M | $10M | $8M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CING viewer.
About TickerBase · Data methodology & sources